Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pituitary Neoplasms 7Prolactinoma 5Polycystic Ovary Syndrome 3Pituitary ACTH Hypersecretion 3Hyperprolactinemia 2Acromegaly 2Recurrence 1Prostatic Neoplasms 1Prolactin Deficiency, Isolated 1Ovarian Hyperstimulation Syndrome 1Neuroendocrine Tumors 1Neoplasms 1Melanoma 1Dumping Syndrome 1Breast Neoplasms 1Brain Neoplasms 1Adrenocortical Hyperfunction 1Adenoma 1ACTH-Secreting Pituitary Adenoma 1

Interventions

Colonoscopy 16Water 3Aspirin 3Ursodeoxycholic Acid 2Sunitinib 2Narrow Band Imaging 2Folic Acid 2Endoscopic Mucosal Resection 2Calcium Carbonate 2pegvisomant 1defactinib 1S-Adenosylmethionine 1Reference Standards 1Polyethylene Glycols 1Octreotide 1Occult Blood 1Methods 1Mesalamine 1Mass Screening 1Injections 1Indocyanine Green 1Endoscopy 1Drug Evaluation 1Diet, Fat-Restricted 1Diagnostic Tests, Routine 1Cholecystectomy 1Cholecalciferol 1Celecoxib 1Calcitriol 1Cabergoline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adenoma × Cabergoline × Clear all
NCT02288962 2025-06-08

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

St. Olavs Hospital

Phase 3 Active not recruiting
60 enrolled
Endocrine

Adenoma, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡